Thomas Wolff
- Pharmacology top 0.5%
- Molecular Biology
- Oncology top 10%
- General Health Professions top 5%
- Cancer Research top 10%
- Co-authors
- F. Peter GuengerichRonald A. LubetRaymond W. NimsM.D. BurkeJohn W. CameronRichard T. MayerHelmut GreimMou‐Tuan Huang
- Topics
- Pharmacogenetics and Drug Metabolism (13 papers)Drug Transport and Resistance Mechanisms (4 papers)Eicosanoids and Hypertension Pharmacology (4 papers)
- Journals
- The American Journal of MedicineEuropean Journal of BiochemistryArchives of Biochemistry and Biophysics
- Partner nations
- GermanyUnited StatesCzechia
In The Last Decade
Thomas Wolff
23 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Pharmacology 610
- Molecular Biology 295
- Oncology 245
- General Health Professions 212
- Cancer Research 165
Countries citing papers authored by Thomas Wolff
This map shows the geographic impact of Thomas Wolff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Wolff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Wolff more than expected).
Fields of papers citing papers by Thomas Wolff
This network shows the impact of papers produced by Thomas Wolff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Wolff. The network helps show where Thomas Wolff may publish in the future.
Co-authorship network of co-authors of Thomas Wolff
This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Wolff. A scholar is included among the top collaborators of Thomas Wolff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Wolff. Thomas Wolff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 9 | |
| 3 | 7 | |
| 4 | 36 | |
| 5 | 111 | |
| 6 | 1 | |
| 7 | 15 | |
| 8 | 29 | |
| 9 | 6 | |
| 10 | 2 | |
| 11 | 26 | |
| 12 | 7 | |
| 13 | 4 | |
| 14 | 14 | |
| 15 | Dealkylation of pentoxyresorufin: A rapid and sensitive assay for measuring induction of cytochrome(s) P-450 by phenobarbital and other xenobiotics in the ratbreakdown → | 621 |
| 16 | 9 | |
| 17 | 7 | |
| 18 | 47 | |
| 19 | 20 | |
| 20 | Modification of group therapy for use on the college campus. | 1 |
About Thomas Wolff
Thomas Wolff is a scholar working on Pharmacology, Biochemistry and Health Information Management, having authored 25 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (13 papers), Drug Transport and Resistance Mechanisms (4 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). The work is most often cited by research in Pharmacology (610 citations), Biochemistry (143 citations) and Cancer Research (165 citations). Thomas Wolff has collaborated with scholars based in Germany, United States and Czechia. Frequent co-authors include F. Peter Guengerich, Ronald A. Lubet, Raymond W. Nims, M.D. Burke, John W. Cameron, Richard T. Mayer, F. Peter Guengerich, Helmut Greim, Mou‐Tuan Huang and Gerald T. Miwa. Their work appears in journals such as The American Journal of Medicine, European Journal of Biochemistry and Archives of Biochemistry and Biophysics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.